Aon (AON) delivered mixed results for Q4 2024 as adjusted EPS beat, but revenue missed Wall Street expectations. The ...

General Dynamics presents a compelling value opportunity amid recent share price weakness, despite strong operational ...

Biogen (BIIB) stock in focus as company and partner Eisai (ESALF) face delay in the EU launch of Alzheimer's drug lecanemab.

Nucor's stock is a buy with 4% boost and potential for 23% upside, supported by strong cash generation and trade policy ...

Bristol-Myers Squibb gets rated a hold, as I see future value in its clinical portfolio and pipeline, particularly ...

Flagstar Financial’s turnaround efforts drive a 15.2% surge. Read why FLG stock is a speculative buy with potential for ...

Elemental Altus Royalties shows strong growth but volatile stock performance. Learn why ELE:CA stock is rated "Hold" while ...

Oil may be exempt from new tariffs despite President Trump's threats due to the complex nature of the U.S. energy industry.

Wizz Air stock fell due to Q3 results, revised 2025 outlook, and fleet plan, highlighting high-risk but potentially ...

Google's near-term potential looks bright. Click here to read more on how AI can help improve the outlook for GOOGL stock.

J. M. Smucker is undervalued at a forward PE of 10.7x, offering a solid 4.1% dividend yield with a well-covered 41% payout ...

Baker Hughes posted solid growth, driven by IET and US LNG demand. Find out why BKR stock’s fair valuation and capped oil ...